Cite

HARVARD Citation

    Dreno, B. et al. (2014). Clinical Benefit Assessment of Vismodegib Therapy in Patients With Advanced Basal Cell Carcinoma. Oncologist. pp. 790-796. [Online]. 
  
Back to record